THY1 and hepatocellular carcinoma: Previous studies have shown that CD90, EpCAM, CD133, CD24, OV-6 and CD44 can be used as CSC markers in HCC, and cells expressing these markers possessed CSC characteristics such as self-renewal, tumor generation and aggressive growth [5–10].